|
|
|
|
Archives
|
Entry
|
Author
|
Date
|
Location
|
|
Immune Design Gets New CEO, Seattle Biomed Nabs $9M, VCs Turn Up Heat on FDA, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
04/28/11 |
Seattle
|
|
Acucela Adds Finance Chief
|
Luke Timmerman |
04/26/11 |
Seattle
|
|
Who Will Keep the Flame Alive for Seattle Biotech? Hear From the Players Nov. 29
|
Luke Timmerman |
11/09/10 |
Seattle
|
|
Seattle Genetics’ Home Run, Acucela Growing Ties to Japan, Calistoga’s Wall Street Guy, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
09/30/10 |
Seattle
|
|
Acucela, Strengthening Ties With Japan’s Otsuka, Gets Right to Develop New Glaucoma Drug
|
Luke Timmerman |
09/27/10 |
Seattle
|
|
FDA Panel Slams Cell Therapeutics, Oncothyreon Slumps, Biotech’s Healthcare Victory, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
03/25/10 |
Seattle
|
|
Innovation Northwest Wrapup: Alder, Tekmira, Acucela, & Other Emerging Little Biotechs
|
Luke Timmerman |
03/19/10 |
Seattle
|
|
Burrill on How Dx Will Beat Rx, VCs Rip Into Pols, Tekmira Strikes Pfizer Deal, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
03/18/10 |
Seattle
|
|
Acucela Gets FDA Fast Track
|
Luke Timmerman |
03/17/10 |
Seattle
|
|
Biotech Bigwig, Steve Burrill, Brings National Profile to Local Conference
|
Luke Timmerman |
01/29/10 |
Seattle
|
|
Dendreon’s New Operations Man, Acucela Enters Fast Growth Phase, JP Morgan Recap, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
01/21/10 |
Seattle
|
|
Acucela Enters Fast-Growth Phase As Macular Degeneration Drug Advances to Key Trial
|
Luke Timmerman |
01/20/10 |
Seattle
|
|
Amazon Closes Zappos Deal, RF Arrays Raises Cash, 16 Under the Radar Financings, & More Seattle-Area Deals News
|
Gregory T. Huang |
11/03/09 |
Seattle
|
|
Under the Radar Deals: 16 Northwest Financings You Haven’t Heard About
|
Gregory T. Huang |
10/28/09 |
Seattle
|
|
Seattle Genetics Recruits at Warp Speed, Amgen Passes Cancer Test, Stephen Friend’s Adventure & More Seattle-Area Life Sciences News
|
Luke Timmerman |
08/13/09 |
Seattle
|
|
Universal Healthcare Can Save Money, But Innovation Is Key: My Experiences in Japan and the U.S.
|
Ryo Kubota |
08/10/09 |
National
|
|
Inside a Life Sciences Industry Confab: Notes from Convergence
|
Ryan McBride |
06/17/09 |
Boston
|
|
Dendreon’s Hiring Binge, Calistoga’s Venture Round, ZymoGenetics Unloads Drugs, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
05/07/09 |
Seattle
|
|
Acucela Drug for Macular Degeneration Passes Early Safety Test
|
Luke Timmerman |
05/06/09 |
Seattle
|
|
Acucela Cuts Staff, Shifting Focus to Development of Eye Disease Drugs
|
Luke Timmerman |
10/03/08 |
Seattle
|
|
Seattle Entrepreneurs Call Bay Area VCs, Amazon Sells XOs, Tableau Taps $10M, ZymoGenetics Gives Up Drug Rights, & More Deals News
|
Robert Buderi |
09/09/08 |
Seattle
|
|
Acucela Strikes Deal With Otsuka Pharmaceutical to Develop Drug for Eye Disease
|
Luke Timmerman |
09/04/08 |
Seattle
|
|
Page 1 of
1 |
|
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.
© 2007-2012, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.
Site produced by Andrew Koyfman with design from Rob Hunter.